Debasmita Mohanty | Microbiology | Best Researcher Award

Posted on by ScienceFather

Ms. Debasmita Mohanty | Microbiology | Best Researcher Award

ICAR-CIFRI, India

Author Profile

Early Academic Pursuits 📚

Debasmita Mohanty’s academic path in the realm of biotechnology and microbiology started with a strong foundation in science. Her journey began at Sailabala Women’s College in Cuttack, Odisha, where she completed her +2 Science in 2011. She then pursued a Bachelor’s in Microbiology (Honors) from the College of Basic Science and Humanities, Bhubaneswar, Odisha, graduating in 2014 with a solid grounding in microbiology and a score of 66.8%.Her academic pursuits deepened as she joined Utkal University in Bhubaneswar, Odisha, for her Master’s in Applied Microbiology, completing it in 2016 with an impressive 79.4% score. Her master’s thesis explored the beneficial effects of Bacillus subtilis and Clostridium butyricum in Labeo rohita, a species of fish, to combat Aeromonas hydrophila infections. Her work highlighted the importance of beneficial microbes in enhancing fish immunity, a field with significant implications for aquaculture sustainability.In pursuit of advanced knowledge and research, Debasmita embarked on a Ph.D. at Fakir Mohan University, Balasore. Her doctoral research focuses on understanding antimicrobial resistance among Aeromonas spp., with a special emphasis on Extended-Spectrum β-Lactamase (ESBL) resistance in aquatic ecosystems. This critical work aims to address the emerging threats of antimicrobial resistance in water bodies, shedding light on the broader impact of microbial evolution on aquatic life and human health.

Professional Endeavors and Work Experience 🏢

Debasmita began her professional journey in biotechnology and research at ICAR-Central Inland Fisheries Research Institute (CIFRI), Barrackpore. Her initial role as Skilled Supporting Staff in 2018 involved work on the “Determination of e-flow for non-lean and non-monsoon months in respect of Teesta Stage-IV HE Project, Sikkim.” This experience laid the groundwork for her understanding of water resource management and environmental assessments.Following this, she joined a project on “Antimicrobial Resistance in Aquaculture and Fisheries” as Young Professional II at ICAR-CIFRI from May 2018 to November 2023. Her role contributed significantly to understanding the growing issue of antimicrobial resistance in aquaculture, a sector crucial for food security. Her responsibilities included analyzing the impact of antimicrobial agents used in fish farming, investigating microbial resistance patterns, and identifying potential mitigation strategies to combat microbial resistance in aquatic environments.Currently, Debasmita serves as a Project Assistant for the National Mission for Clean Ganga at ICAR-CIFRI. Since November 2024, she has been engaged in research that aims to restore and protect the river Ganga’s ecosystem by focusing on water quality, pollutant reduction, and microbial health. Her work aligns with broader goals of promoting environmental sustainability and conserving aquatic biodiversity, showing her dedication to public welfare and sustainable practices.

Contributions and Research Focus 🌊🧪

Debasmita’s research is centered on combating antimicrobial resistance (AMR) within aquaculture and water ecosystems. Her current focus on ESBL resistance among Aeromonas spp. addresses a serious challenge in the field of environmental microbiology. The findings from her studies contribute to developing guidelines on the responsible use of antimicrobials in aquaculture, aiming to safeguard both human health and ecological balance.Her studies on beneficial microbes’ role in protecting aquaculture species, such as Labeo rohita, highlight her proactive approach toward biosecurity and sustainability. She has contributed valuable insights into microbial therapies as alternative health solutions, reducing the reliance on chemical interventions and fostering healthier ecosystems.

Accolades and Recognition 🏆🌟

Throughout her academic and professional career, Debasmita has demonstrated a commitment to excellence in microbial research and environmental conservation. Her projects with ICAR-CIFRI have not only strengthened her expertise but also positioned her as an advocate for antimicrobial resistance awareness and sustainable practices in aquaculture. Although formal accolades are not detailed, her dedication and impactful work in environmental microbiology and sustainable aquaculture resonate as professional achievements.

Impact and Influence 🌍💧

Debasmita’s work in microbial resistance and sustainable aquaculture resonates with the global push toward environmental sustainability and safe food practices. Her involvement in the National Mission for Clean Ganga aligns with India’s vision for preserving natural resources, especially its critical water bodies. By understanding and mitigating antimicrobial resistance within aquatic ecosystems, Debasmita’s contributions aid in preserving biodiversity and ensuring food safety for future generations.

Legacy and Future Contributions 🔬🌱

Looking ahead, Debasmita Mohanty is likely to continue making strides in environmental biotechnology, with a focus on microbial resistance and sustainable aquaculture practices. Her current research is paving the way for safer aquaculture methodologies, enhanced water management policies, and more effective strategies for combating antimicrobial resistance. She aspires to develop innovative solutions that benefit both ecosystems and communities, bridging the gap between scientific research and practical applications.In summary, Debasmita Mohanty’s journey reflects a dedication to scientific research, environmental conservation, and public welfare. Through her studies, she is shaping a legacy that will inspire future biotechnologists and environmental scientists, contributing to a more sustainable and resilient world. 🌎

Citations

A total of 137 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         137
  • h-index           14
  • i10-index        04

Notable Publications 

  • Prevalence of Extended-Spectrum β-Lactamases (ESBLs) Producing Aeromonas spp. Isolated from Lamellidens marginalis (Lamark, 1819) of Sewage-Fed Wetland: A Phenotypic and Genotypic Approach
    • Authors: Mohanty, D., Das, B.K., Kumari, P., Dasgupta, S., Roy, S.
    • Journal: Microorganisms
    • Year: 2024.
  • Immunomodulatory Effect of Saponin Treatment and Microbial Infections Provoking the Expression of Mx Gene in Catla (Labeo catla)
    • Authors: Panda, S.P., Soren, D., Roy, P., Sahoo, A.K., Das, B.K.
    • Journal: Aquaculture International
    • Year: 2024.
  • Bacillus subtilis and Saccharomyces cerevisiae as Potential Modulators of Hemato-Biochemical Indices, Digestive Enzymes and Disease Resistance in Labeo rohita
    • Authors: Baisakhi, B., Swain, H.S., Bera, A.K., Upadhyay, A., Mohanty, D.
    • Journal: Agricultural Research
    • Year: 2024.
  • Chitosan Extracted from Portunus sanguinolentus (Three-Spot Swimming Crab) Shells: Its Physico-Chemical and Biological Potentials
    • Authors: Pradhan, J., Baisakhi, B., Das, B.K., Ananta, S., Mohanty, D.
    • Journal: Journal of Environmental Biology
    • Year: 2024.
  • Synthesis of Chitosan Nanoparticles from Tasar Silkworm, Antheraea mylitta Pupae and Its Antioxidant Efficacy and Antibacterial Activity Against Fish Pathogens
    • Authors: Baisakhi, B., Mohanty, D., Das, B.K., Jena, K., Pradhan, J.
    • Journal: Journal of Environmental Biology
    • Year: 2023.

Sushil Kumar Sharma | Microbiology | Outstanding Scientist Award

Posted on by ScienceFather

Dr. Sushil Kumar Sharma | Microbiology | Outstanding Scientist Award

ICAR-National Institute of Biotic Stress Management, Raipur, Chhattisgarh, India

Author Profile

Early Academic Pursuits 🎓📚

Dr. Sushil Kumar Sharma began his academic journey with a passion for agricultural microbiology, a field critical for advancing sustainable agricultural practices in India. His foundational studies laid a strong groundwork in microbiology and plant science, equipping him with the tools to make substantial contributions to the scientific community. He quickly progressed in academia, earning advanced degrees that honed his expertise in rhizobiology, soil microbiology, and the application of microorganisms in agriculture. This robust academic background paved the way for his long and impactful career within the Indian Council of Agricultural Research (ICAR) institutions, where he has focused on innovative solutions to agricultural challenges through microbial research.

Professional Endeavors 🧑‍🔬💼

Dr. Sharma’s professional career spans over three decades, marked by his dedication to agricultural microbiology within prestigious ICAR institutions. Currently, he serves as a Principal Scientist at the ICAR-National Institute of Biotic Stress Management (NIBSM) in Raipur, Chhattisgarh, a position he has held for the past five years. Before joining NIBSM, Dr. Sharma served over six years at the ICAR-National Bureau of Agriculturally Important Microorganisms (NBAIM) in Maunath Bhanjan, Uttar Pradesh, where he held the important role of In-charge of the National Agriculturally Important Microbial Culture Collection (NAIMCC). In this role, he coordinated daily activities involving the culture collection with the help of a dedicated team of scientists and technical staff. His experience also includes a significant 15-year tenure at the ICAR-Indian Institute of Soybean Research (IISR) in Indore, Madhya Pradesh, where he specialized in rhizobiology specific to soybean and wheat crops, contributing to enhancing crop productivity through microbial interventions.

Contributions and Research Focus 🌱🔍

Dr. Sharma’s research focus has been on harnessing beneficial microorganisms to improve agricultural productivity and sustainability. His work on rhizobiology, specifically related to soybean, has been transformative, leading to the identification of efficient strains of rhizobia and plant growth-promoting rhizobacteria. As part of his efforts, he contributed to the development of on-farm production techniques for arbuscular mycorrhizal (AM) fungi propagules, which are beneficial to crop health and soil structure. This breakthrough has allowed farmers to integrate microbial solutions into their practices, reducing reliance on chemical inputs. Furthermore, Dr. Sharma’s work at ICAR-Central Arid Zone Research Institute (CAZRI) involved developing a non-chemical biofumigation method using cruciferous plant residues to control soil-borne pathogens in arid legume crops. This innovative solution, which utilizes natural summer heating, was a significant advancement in protecting legume crops without resorting to synthetic chemicals.

Accolades and Recognition 🏆🌍

Dr. Sharma’s exemplary work has garnered both national and international recognition. He has received the prestigious “Best Scientist” award from the PEARL Foundation in Madurai, India, as well as the “Excellence in PGPR Research” award from the Asian PGPR Society. His invited talks at prominent conferences, such as the International PGPR Conference in Medellin, Colombia, in 2012, and the Asian PGPR Conference in Tashkent, Uzbekistan, in 2019, showcase his status as a thought leader in his field. His selection as a member of the Biosafety and Biosecurity Cell (B2Cell) at the Indian Council of Medical Research (ICMR) in New Delhi is a testament to his contributions to microbial biosafety in agriculture.

Impact and Influence 🌏💪

Dr. Sharma’s contributions have far-reaching impacts beyond his immediate research environment. His work in microbial culture collection, development of bio-fumigation methods, and the advancement of microbial applications in agriculture have equipped farmers with sustainable practices that enhance crop resilience and soil health. By promoting bio-based solutions, Dr. Sharma has influenced a shift toward organic and eco-friendly agricultural practices that reduce dependency on synthetic chemicals and foster a healthier ecosystem.As a key player in the ICAR-AICRP (All India Coordinated Research Project) on Soybean, Dr. Sharma contributed to national research efforts aimed at evaluating the effectiveness of microbial products on crop growth, aiding in the development of improved agricultural strategies. His contributions extend to institutional development, as he also held the role of Acting Director at ICAR-NBAIM for a five-month period, during which he undertook crucial administrative and financial responsibilities.

Legacy and Future Contributions 🔬🚀

Dr. Sharma’s research legacy in agricultural microbiology continues to thrive through his mentorship of young scientists and researchers. With over 110 research articles, reviews, and book chapters published in national and international journals and conference proceedings, Dr. Sharma has made substantial scholarly contributions to the field of microbiology. His work in advancing microbial solutions in agriculture is inspiring a new generation of researchers dedicated to sustainable farming practices.Looking ahead, Dr. Sharma is poised to further his research and leadership in microbiological applications, particularly in biotic stress management. His role at NIBSM will likely focus on pioneering biocontrol methods and advancing microbial biotechnology to mitigate stress factors affecting crops due to climate change, pests, and diseases. This dedication to exploring innovative biotechnological solutions promises to leave a lasting impact on both the scientific community and agricultural practices, reinforcing the resilience and sustainability of India’s agricultural sector.

Conclusion 🌾🌐

In summary, Dr. Sushil Kumar Sharma’s career is a testament to the power of scientific innovation and its practical applications in addressing agricultural challenges. From his early research pursuits to his transformative contributions to microbial applications, Dr. Sharma has played an influential role in promoting sustainable agricultural practices through microbiology. His work not only enhances crop productivity but also promotes a healthier, more resilient agricultural system, leaving a legacy that will continue to inspire future generations of scientists and farmers alike.

Citations

A total of 2397 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        2397
  • h-index          23
  • i10-index       35

Notable Publications 

  1. “Inoculation of zinc solubilizing Bacillus aryabhattai strains for improved growth, mobilization and biofortification of zinc in soybean and wheat cultivated in Vertisols”
    Authors: A. Ramesh, S.K. Sharma, M.P. Sharma, N. Yadav, O.P. Joshi
    Journal: Applied Soil Ecology, 2014.
  2. “Microbial community structure and diversity as indicators for evaluating soil quality”
    Authors: S.K. Sharma, A. Ramesh, M.P. Sharma, O.P. Joshi, B. Govaerts, et al.
    Journal: Biodiversity, Biofuels, Agroforestry and Conservation Agriculture, 2011.
  3. “Characterization of zinc-solubilizing Bacillus isolates and their potential to influence zinc assimilation in soybean seeds”
    Authors: S.K. Sharma, M.P. Sharma, A. Ramesh, O.P. Joshi
    Journal: Journal of Microbiology and Biotechnology, 2012.
  4. “Zinc solubilizing Bacillus strains that modulate growth, yield and zinc biofortification of soybean and wheat”
    Authors: R. Khande, S.K. Sharma, A. Ramesh, M.P. Sharma
    Journal: Rhizosphere, 2017.
  5. “Plant Growth-Promoting Traits in Enterobacter cloacae subsp. dissolvens MDSR9 Isolated from Soybean Rhizosphere and its Impact on Growth and Nutrition of Soybean”
    Authors: A. Ramesh, S.K. Sharma, M.P. Sharma, N. Yadav, O.P. Joshi
    Journal: Agricultural Research, 2014.

Sunil Roy | Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Sunil Roy | Microbiology | Best Researcher Award

Thottuvelil Aster Medcity, Kochi, India

Author Profile

Early Academic Pursuits 🎓

Dr. Sunil Roy Narayanan began his educational journey in medicine with an MBBS degree from T.D. Medical College, Kerala University, India, in 1992. His commitment to the field was evident early on, as he pursued further specialization in General Medicine, completing his MD at JIPMER, Pondicherry University, in 1998. This foundational education set the stage for his passion for cardiology. Dr. Narayanan continued his academic excellence by obtaining a DM in Cardiology from G.B. Pant Hospital, Delhi University, in 2005, where he honed his skills in this vital field. His rigorous training and early exposure to the complexities of cardiac care positioned him as a promising figure in interventional cardiology.

Professional Endeavors 💼

Dr. Narayanan’s professional journey is marked by significant roles in esteemed institutions. He is currently a Consultant Interventional Cardiologist at Aster Medcity in Kochi, India, where he has been instrumental since 2019. Prior to this, he served as a Consultant at Belhoul Specialty Hospital in Dubai, UAE, from 2016 to 2019. His career at Belhoul began in 2006, where he worked as a Specialist Cardiologist for a decade, contributing extensively to the department’s growth.Before his time in Dubai, Dr. Narayanan played a vital role as a Senior Lecturer in Cardiology at Government Medical College, Calicut, from 1998 to 2006. His dual role as an educator and practitioner allowed him to influence the next generation of cardiologists, emphasizing both clinical skills and theoretical knowledge.

Contributions and Research Focus 🔬

Dr. Narayanan’s research endeavors are as impressive as his clinical work. His focus has been on enhancing patient outcomes through innovative approaches. As the Principal Investigator (PI) for several projects, he has explored critical areas such as the comparison of NLR, PLR, and SII in predicting mortality in infective endocarditis, and the effectiveness of wearable monitoring in heart failure patients. His work has attracted funding from Aster DM Healthcare, emphasizing the importance of his research in the medical community.Ongoing research projects, including the investigation of vascular versus chronological age in myocardial infarction, showcase his dedication to advancing cardiology. His contributions extend beyond clinical practice; they aim to reshape how cardiovascular diseases are understood and managed.

Accolades and Recognition 🏆

Dr. Narayanan’s commitment to excellence has not gone unnoticed. He received the prestigious Hind Rattan Award in 2015 from the NRI Welfare Society of India, recognizing his outstanding contributions to medicine and society. Additionally, he was honored with the Shri Venkatasubba Reddiar Memorial Prize for being the Best Postgraduate Student in Cardiology at JIPMER in 1998. His commitment to scholarship is further reflected in his certifications for outstanding contributions in reviewing articles for esteemed journals, such as the International Journal of Cardiology and the Indian Heart Journal.These accolades not only highlight Dr. Narayanan’s expertise but also signify his dedication to upholding high standards in medical practice and research.

Impact and Influence 🌍

Dr. Narayanan’s influence extends beyond the confines of his roles; he is a mentor and a leader in the cardiology community. As a Fellow of various prestigious organizations, including the American College of Cardiology (FACC) and the European Society of Cardiology (FESC), he is actively involved in shaping the future of cardiology through education and professional development. His participation in advanced training programs, such as the GCSRT Fellowship at Harvard Medical School, reflects his commitment to lifelong learning and adapting to emerging medical practices.Through his various roles, Dr. Narayanan has significantly impacted patient care, particularly in interventional cardiology, where he has championed the use of cutting-edge techniques and technologies.

Legacy and Future Contributions 🔮

Dr. Narayanan’s legacy is one of compassion, dedication, and innovation in the field of cardiology. As he continues his work at Aster Medcity, he is poised to influence future generations of cardiologists and improve patient care in cardiology. His ongoing research projects and commitment to professional development ensure that his contributions will have a lasting impact on the field.Looking ahead, Dr. Narayanan aims to expand his research in predictive analytics in cardiology, focusing on integrating technology into patient care. His vision includes enhancing the use of wearable technology for real-time monitoring of cardiac patients, ultimately improving health outcomes.In summary, Dr. Sunil Roy Narayanan stands as a pillar in the medical community, with a career characterized by academic excellence, professional achievement, and a profound commitment to patient care and medical advancement. His future contributions are likely to continue reshaping the landscape of cardiology, making a significant difference in the lives of countless patients.

Notable Publications 

  • Title: Anomalous origin of RCA from left coronary sinus presenting as PSVT and recurrent acute coronary syndromes
    Author: Sunil Roy Thottuvelil Narayanan
    Journal: Indian Heart Journal
    Year: 2016.
  • Title: Acute Inferior Wall Myocardial Infarction due to Occlusion of the Wrapped Left Anterior Descending Coronary Artery
    Author: Sunil Roy Thottuvelil Narayanan
    Journal: Case Reports in Cardiology
    Year: 2013.
  • Title: Angle correction for proximal isovelocity surface area method: Is it spheric cap or lune?
    Author: Sunil Roy Thottuvelil Narayanan
    Journal: Journal of the American Society of Echocardiography
    Year: 2006.
  • Title: Comparison of proximal isovelocity surface area method and pressure half time method for evaluation of mitral valve area in patients undergoing balloon mitral valvotomy
    Author: Sunil Roy Thottuvelil Narayanan
    Journal: Echocardiography
    Year: 2005.
  • Title: Novel non-surgical method of managing cardiac perforation during percutaneous transvenous mitral commissurotomy
    Author: Sunil Roy Thottuvelil Narayanan
    Journal: Indian Heart Journal
    Year: 2004.

Vinay Modgil | Medical microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Vinay Modgil | Medical microbiology | Best Researcher Award

HISP, India

Author Profile

Early Academic Pursuits 🎓📘

Dr. Vinay Modgil’s academic journey began in Himachal Pradesh, where he pursued his B.Sc. in Medical Sciences at Himachal Pradesh University (HPU), Shimla, from 2006 to 2009. His strong academic foundation continued with an M.Sc. in Biotechnology from the same institution, completed between 2009 and 2011. These formative years instilled in him a solid understanding of life sciences and biotechnology, laying the groundwork for his future endeavors.Following his master’s degree, Dr. Modgil’s thirst for knowledge led him to pursue a Ph.D. in Medical Microbiology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, between 2015 and 2020. His doctoral research allowed him to dive deep into the intricacies of medical microbiology, a field of growing significance, especially in the context of global health challenges like antimicrobial resistance (AMR) and infectious diseases. His academic journey demonstrates a commitment to understanding both the theoretical and practical aspects of microbiology, biotechnology, and medical sciences.

Professional Endeavors 🧑‍🔬💼

After completing his Ph.D., Dr. Modgil took on a crucial role as a Senior Researcher in the Department of Medical Microbiology at PGIMER, Chandigarh. This position, which he held from February 2021 to May 2023, marked his transition from academic research to a professional career, blending scientific inquiry with real-world applications. His research here focused on data analysis in medical microbiology, particularly surrounding infection control and antibiotic stewardship—a growing need in healthcare systems globally.In May 2023, Dr. Modgil advanced to a Senior Data Scientist role at the Society for Health Information Systems Programmes (HISP India). Here, he shifted focus to health data management, specifically within the District Health Information System (DHIS2) for the Equity AMR project. His work involves overseeing data analysis related to antimicrobial resistance, a global public health crisis. By analyzing and interpreting vast datasets—ranging from antibiotic susceptibility tests (AST) to prescription patterns—Dr. Modgil plays a pivotal role in guiding empirical therapy decisions and supporting the development of antibiotic stewardship policies.

Contributions and Research Focus 🔬📊

Dr. Modgil’s research focus centers on one of the most pressing issues in global healthcare: antimicrobial resistance (AMR). As part of his role at HISP India, he is responsible for all data-related activities in the Equity AMR project, which operates across healthcare facilities in Himachal Pradesh and Bihar. His expertise in analyzing infection patterns, prescription trends, and AST data helps improve healthcare systems’ responses to AMR.In addition to data analysis, Dr. Modgil has also conducted point prevalence studies in various healthcare facilities, enhancing the understanding of infection trends. His collaborative work with microbiologists, clinicians, and hospital administrators helps to shape policy and empirical therapy, based on comprehensive data interpretations. These activities reflect his ability to not only analyze data but also to translate it into actionable insights that improve patient outcomes and public health strategies.His role in capacity building—training HISP India team members and state facilities on data analysis—further highlights his contribution to strengthening the healthcare system’s response to AMR. By improving the skills of healthcare professionals in data interpretation, he is helping build a sustainable infrastructure for continuous AMR surveillance and action.

Accolades and Recognition 🏅👏

While Dr. Modgil’s career is still relatively early, his impact is already evident in his growing body of work on AMR surveillance. His dedication to improving data analysis for AMR trends and his role in implementing data-driven policies in hospitals underscore his emerging leadership in the field of medical microbiology and data science.Although there are no specific awards listed in his resume, Dr. Modgil’s selection as Senior Data Scientist at HISP India—a role pivotal in the fight against antimicrobial resistance—reflects a recognition of his technical expertise and leadership abilities. His responsibility in guiding data analysis for such a critical public health issue speaks volumes about the trust and reliance placed in him by his peers and superiors.

Impact and Influence 🌍📈

Dr. Modgil’s influence extends beyond individual projects or datasets. His work is pivotal in shaping how health information systems approach antimicrobial resistance. By analyzing trends across various healthcare facilities and working with multiple stakeholders, including hospital administrators and policymakers, he plays a vital role in ensuring that healthcare practices align with the latest data and trends.Furthermore, his efforts in capacity building ensure that healthcare teams in both Himachal Pradesh and Bihar can effectively utilize data for decision-making. This is crucial for sustaining improvements in AMR surveillance and making the healthcare system more resilient against future challenges.

Legacy and Future Contributions 💡🚀

Looking ahead, Dr. Modgil’s contributions are likely to leave a lasting legacy in the field of health data science, particularly in the domain of AMR. His focus on integrating data analysis with clinical decision-making, combined with his hands-on approach to training and capacity building, will have a long-term impact on how healthcare systems respond to antimicrobial resistance.As he continues to refine data collection, analysis, and reporting processes in the Equity AMR project, Dr. Modgil’s work will likely lead to more effective stewardship policies and empirical treatments that can be scaled across regions. His ability to bridge the gap between data science and clinical practice positions him as a key figure in addressing one of the most significant public health threats of the 21st century.

Citations

A total of 61 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         61
  • h-index           14
  • i10-index        5

Notable Publications

  • Title: Sequence types of enteroaggregative Escherichia coli strains recovered from human, animal, and environmental sources: India
    Authors: Modgil, V., Kaur, H., Mahindroo, J., Mohan, B., Taneja, N.
    Journal: Gene Reports
    Year: 2024.
  • Title: Antimicrobial resistance in food-borne pathogens at the human-animal interface: Results from a large surveillance study in India
    Authors: Mahindroo, J., Narayan, C., Modgil, V., Mohan, B., Taneja, N.
    Journal: One Health
    Year: 2024.
  • Title: Genome sequence of pan drug-resistant enteroaggregative Escherichia coli belonging to ST38 clone from India, an emerging EAEC/UPEC hybrid pathotype
    Authors: Kaur, H., Singh, I., Modgil, V., Mohan, B., Taneja, N.
    Journal: Indian Journal of Medical Microbiology
    Year: 2024.
  • Title: Association of Putative Virulence Genes with HEp-2 Cell Adherence and Biofilm Production in Enteroaggregative Escherichia coli Strains Isolated from Acute Diarrheal and Healthy Children, India
    Authors: Modgil, V., Kaur, H., Mohan, B., Taneja, N.
    Journal: Indian Journal of Microbiology
    Year: 2024.
  • Title: Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic Escherichia coli
    Authors: Kaur, H., Modgil, V., Chaudhary, N., Mohan, B., Taneja, N.
    Journal: Biomedicines
    Year: 2023.

Nitin Pal Kalia | Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Nitin Pal Kalia | Microbiology | Best Researcher Award

National Institute of Pharmaceutical Education and Research Hyderabad- India

Author Profile

🎓Early Academic Pursuits

Nitin Pal Kalia embarked on his academic journey with a focus on biotechnology and clinical microbiology. He completed his M.Sc. in Biotechnology with first-class honors from Guru Nanak Dev University, Amritsar, Punjab, India, in 2006. His passion for research led him to pursue a Ph.D. in the Clinical Microbiology Division at the Indian Institute of Integrative Medicine (IIIM), Jammu, under the guidance of Dr. Inshad Ali Khan. During his doctoral studies (2007-2014), Dr. Kalia made significant contributions to the field, including groundbreaking work on the NorA efflux pump inhibitor capsaicin and its impact on Staphylococcus aureus.

🧑‍🏫Professional Endeavors 

Assistant Professor at NIPER-Hyderabad

Since February 2021, Nitin Pal Kalia has been serving as an Assistant Professor in the Department of Biological Sciences at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. His office, Room No. 63, has become a hub for innovative research and academic excellence.

Ramalingaswami Fellow

From August 2019 to February 2021, Dr. Kalia held the prestigious Ramalingaswami Fellowship at CSIR-IIIM, Jammu, India. This fellowship allowed him to further his research in drug discovery and tuberculosis.

Research Fellow at NTU Singapore

Between October 2015 and August 2019, Dr. Kalia was a Research Fellow at the Lee Kong Chian School of Medicine, NTU Singapore. Here, he honed his skills in advanced research methodologies and contributed to significant scientific discoveries.

Visiting Fellow at NIAID-NIH

Dr. Kalia also spent time as a Visiting Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, USA, from May 2014 to July 2015. This experience enriched his research capabilities, particularly in the field of tuberculosis and mycobacteria.

🔬Contributions and Research Focus

Drug Discovery in Tuberculosis

Dr. Kalia’s research has been pivotal in the field of tuberculosis (TB), which remains a major global health challenge. He has focused on discovering new TB drugs and improving the clinical development process for these drugs. His work includes targeting terminal oxidases, specifically the respiratory cytochrome bc1 complex and cytochrome bd-type quinol oxidase, to combat drug-resistant Mycobacterium tuberculosis.

Targeting Cell Wall Synthesis at NIH

During his tenure at NIH, Dr. Kalia evaluated new chemical entities against Mycobacterium tuberculosis mutants. His work aimed to find compounds that target cell wall synthesis, a critical area in TB drug development.

Doctoral Research on Capsaicin

Dr. Kalia’s Ph.D. research revealed capsaicin as an effective inhibitor of the NorA efflux pump in Staphylococcus aureus. His findings demonstrated that capsaicin could significantly reduce the minimum inhibitory concentration of ciprofloxacin and enhance its efficacy, highlighting its potential in overcoming antibiotic resistance.

🏆Accolades and Recognition

Dr. Kalia’s contributions to biomedical research have been recognized through numerous awards and fellowships:

  1. Ramalingaswami Re-entry Fellowship (2017-2018): Awarded by the Department of Biotechnology (DBT), Government of India.
  2. BSL-3 Training: Attended training sessions on biosafety, bio-containment, risk assessment, and management at the National University of Singapore and NIH USA.
  3. IIIM-CSIR Award (2013): Recognized for significant contributions in Discovery Biology, particularly in tuberculosis research.
  4. Indian Council of Medical Research-Senior Research Fellowship: Awarded for his project on evaluating capsaicin and its analogues as multidrug efflux pump inhibitors.

🌍Impact and Influence

Dr. Kalia’s work has had a profound impact on the field of infectious diseases, particularly tuberculosis. His research has paved the way for new drug discoveries and therapeutic strategies. His dedication to teaching and mentoring students at NIPER-Hyderabad has inspired many young minds to pursue careers in biomedical research.

🚀Legacy and Future Contributions

As an Assistant Professor at NIPER-Hyderabad, Dr. Kalia continues to advance the frontiers of biomedical research. His ongoing projects aim to discover new TB drugs and improve existing treatments. Dr. Kalia’s legacy lies in his unwavering commitment to scientific excellence and his ability to inspire future generations of researchers.

Citations

A total of 1513 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        1513
  • h-index           19
  • i10-index        21

Notable Publications 

  • Title: Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase
    • Authors: [Authors not provided]
    • Journal: RSC Medicinal Chemistry
    • Year: 2024
  • Title: Cytochrome bd oxidase: an emerging anti-tubercular drug target
    • Authors: [Authors not provided]
    • Journal: RSC Medicinal Chemistry
    • Year: 2024
  • Title: GaMF1.39’s antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876
    • Authors: [Authors not provided]
    • Journal: Microbiology Spectrum
    • Year: 2023-12-12
  • Title: Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection
    • Authors: [Authors not provided]
    • Journal: European Journal of Clinical Microbiology & Infectious Diseases
    • Year: 2023-11
  • Title: Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the bacilli
    • Authors: [Authors not provided]
    • Journal: Journal of Medical Microbiology
    • Year: 2023-06-01.

Sahjid Mukhida | Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Sahjid Mukhida | Microbiology | Best Researcher Award

GMERS Medical College,Gujarat- India

Author Profile

🎓Early Academic Pursuits

Sahjid Mukhida embarked on a diverse academic journey, beginning with his Bachelor of Ayurvedic Medicine and Surgery (B.A.M.S.) from Govt. Ayurved College, Junagadh in 2007. This early exposure to traditional medicine laid a strong foundation for his future medical career. Driven by a passion for medical science, he pursued a Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) from JIAMUSI UNIVERSITY, China, graduating in June 2019. His education didn’t stop there; he went on to earn an MD in Microbiology from Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune. Additionally, he holds several postgraduate diplomas, including a Post-Graduation Diploma in Hospital Management (P.G.D.H.M.) from Madurai Kamraj University, Tamil Nadu (2010), and a Post-Graduation Diploma in Business Management (P.G.D.B.M.) with a specialization in Clinical Research Management from the Indian School of Business Management, Ahmedabad-Gujarat (2011). His academic pursuits are further complemented by a Professional Diploma in Clinical Research (P.D.C.R.) from Catalyst Clinical Care Institute, New Delhi (2011).

🏥Professional Endeavors

Sahjid Mukhida’s professional journey began as a Medical Supervisor, Apheresis Coordinator, and Quality Manager at Rajkot Voluntary Blood Bank and Research Center (Life Blood Center), Rajkot, Gujarat, from August 2008 to November 2013. During this tenure, he gained significant experience in HPLC testing for Thalassemia and other hemoglobinopathies, genetic counseling, and PND testing. He later joined Kokilaben Dhirubhai Ambani Hospital, Andheri, Mumbai, as a Quality Manager and Blood Transfusion Officer in Transfusion Medicine from October 2019 to July 2020. His role involved ensuring the highest standards in blood transfusion practices.Subsequently, Sahjid served as a Junior Resident in the Department of Microbiology at Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, from August 2020 to August 2023. Here, he honed his skills in various sections of the department, gaining hands-on experience in education, teaching, data analysis, project writing, and publication processes. His role also included organizing and handling conferences, showcasing his leadership and organizational skills.

🔬Contributions and Research Focus

Sahjid Mukhida’s contributions to the field of medicine are multifaceted. His research focuses on blood banking, transfusion medicine, and microbiology. He is adept at using the latest industry equipment and technology to ensure patient and donor safety. His specialization in documentation and patient transfusion/transplant safety underscores his commitment to excellence.His work experience includes significant contributions to the prevention of Thalassemia and other hemoglobinopathies through genetic counseling and PND testing. Additionally, his research on appendicitis among medical students at Jiamusi University and his involvement in various research projects, including a survey on food habits and lifestyle, highlight his dedication to advancing medical knowledge.

🏆Accolades and Recognition

Sahjid Mukhida’s exemplary work has been recognized with numerous accolades. He was awarded the Dr. Harold Gunson Fellowship by the International Society of Blood Transfusion (ISBT) in 2010 and presented a poster at the 31st International Congress of ISBT in Berlin, Germany. He attended the 1st Pan-Asian Conference of Hemoglobinopathies organized by Thalassemia International Federation (TIF) in Bangkok, Thailand, with sponsorship from TIF in February 2012.His excellence has also been acknowledged through various certificates of appreciation, including being named Employee of the Month twice in five years and receiving the Certificate of Excellence Graduates from Jiamusi University in June 2019. He has been trained in quality management systems of NABH, NABL, and ISO 9001:2008, and is an internal auditor and trainer for these certifications. He holds lifetime memberships with the Quality Council of India and ISTM.

🌟Impact and Influence

Sahjid Mukhida’s impact on the medical community is profound. His work in blood banking and transfusion medicine has set high standards for patient safety and quality care. His leadership abilities have enabled him to effectively manage practice staff and improve patient outcomes. His commitment to continuous learning and professional development is evident in his extensive list of certifications and training.

🛤️Legacy and Future Contributions

Looking ahead, Sahjid Mukhida is poised to continue making significant contributions to the medical field. His ongoing involvement in research projects, such as the ICMR study on Mucormycosis, and his dedication to education and training position him as a future leader in medical research and practice. His legacy is one of dedication, excellence, and a relentless pursuit of knowledge, ensuring that his impact will be felt for years to come.In summary, Sahjid Mukhida’s journey from a dedicated student to a respected medical professional is marked by his unwavering commitment to excellence, continuous learning, and a passion for improving patient care. His contributions to blood banking, transfusion medicine, and microbiology, coupled with his leadership skills and professional achievements, make him a notable figure in the medical community.

Citations

A total of 40 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         40
  • h-index           44
  • i10-index        3

Notable Publications 

  • Title: Two Teacher System in Medical Curriculum: An Experiment Worth Considering
    • Authors: Das, N.K., Mukhida, S., Patil, R., Khan, S.
    • Journal: Medical Journal of Dr. D.Y. Patil Vidyapeeth
    • Year: 2024
  • Title: All it Needs a Passionate Teacher to Ignite Young Minds
    • Authors: Das, N.K., Mukhida, S., Ajagunde, J., Das, P.
    • Journal: Journal of Datta Meghe Institute of Medical Sciences University
    • Year: 2024
  • Title: Development of a Machine Learning Model to Predict Risk of Development of COVID-19-Associated Mucormycosis
    • Authors: Patil, R., Mukhida, S., Ajagunde, J., Das, N.K., Mirza, S.
    • Journal: Future Microbiology
    • Year: 2024
  • Title: Baseline Findings of a Multicentric Ambispective Cohort Study (2021–2022) Among Hospitalised Mucormycosis Patients in India
    • Authors: Abdulkader, R.S., Ponnaiah, M., Bhatnagar, T., Murhekar, M.V., Mukhida, S.S.
    • Journal: Mycology
    • Year: 2024.